INDRAMEDCO2023-04-012023-06-30 INDRAMEDCO2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member INDRAMEDCO2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member INDRAMEDCO2023-06-30 INDRAMEDCO2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532150 INDRAMEDCO NOTLISTED Indraprastha Medical Corporation Limited Equity 2023-04-01 2024-03-31 2023-08-04 2023-07-25 INR Crores First quarter 15:00:00 17:15:00 2023-08-04 2023-08-04 Not applicable Single segment HEALTHCARE 2023-04-01 2023-06-30 Unaudited Standalone 3065100000.00 35600000.00 3100700000.00 541800000.00 0.00 0.00 632700000.00 7800000.00 98100000.00 1418000000.00 2698400000.00 402300000.00 0.00 402300000.00 109100000.00 -11800000.00 97300000.00 0.00 305000000.00 0.00 0.00 0.00 0.00 305000000.00 -3400000.00 301600000.00 0.00 0.00 916700000.00 10 3.33 3.33 0.00 0.00 3.33 3.33 1. The above financial results were reviewed by the Audit Committee and have been approved by the Board of Directors at their meeting held on 4th August, 2023. 2. The Company operates in a single segment i.e. Healthcare and hence, does not have any additional disclosures to be made under Ind AS 108 on Operating Segments. 3. The financial results for the three months ended 31st March, 2023 are the balancing figures between the audited figures for the year ended 31st March, 2023 and the unaudited year to date figures for the nine months ending 31st December, 2022, which were subject to limited review. 4. The Code on Social Security, 2020 has been enacted, which could impact the contributions by the company towards Provident Fund and Gratuity. The effective date from which the changes are applicable is yet to be notified. Impact if any, of the change will be assessed and accounted in period of notification of relevant provisions. 5. Previous year/period figures have been regrouped / rearranged wherever necessary. Other Expenses 647700000.00 Professional Charges to doctors 770300000.00 Gratuity Funded -4600000.00 -4600000.00 -1200000.00 0.00